HIV RNA dimerisation interference by antisense oligonucleotides targeted to the 5' UTR structural elements by Reyes-Darias, J. A. et al.
1 
 
                                                                                                                                                                                         
HIV RNA dimerisation interference by antisense 
oligonucleotides targeted to the 5' UTR structural elements 
 
José A. Reyes-Darias, Francisco J. Sánchez-Luque and Alfredo Berzal-Herranz* 
 
Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLN-CSIC), 
Parque Tecnológico de Ciencias de la Salud, 
Av. del Conocimiento s/n, Armilla, 18100 Granada, Spain. 
Tel: +34 958 181 648 
Fax: +34 958 181 632 
 
 
 
*Correspondence should be addressed to: 
Alfredo Berzal-Herranz  
Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLN-CSIC), Parque 
Tecnológico de Ciencias de la Salud, Av. del Conocimiento s/n, Armilla 18100, 
Granada, Spain. 
Tel: +34 958 181 648; Fax: +34 958 181 632; E-mail: aberzalh@ipb.csic.es 
*Manuscript
Click here to view linked References
2 
 
Abstract 1 
The HIV-1 genome consists of two identical RNA molecules non-covalently linked by 2 
their 5‟ unstranslatable regions (5‟UTR). The high level of sequence and structural 3 
conservation of this region correlates with its important functional involvement in the 4 
viral cycle, making it an attractive target for antiviral treatments based on antisense 5 
technology. Ten unmodified DNA antisense oligonucleotides (ODNs) targeted 6 
against different conserved structural elements within the 5‟UTR were assayed for 7 
their capacity to interfere with HIV-1 RNA dimerisation, inhibit gene expression, and 8 
prevent virus production in cell cultures. The results show that, in addition to the well-9 
characterised dimerisation initiation site (DIS), targeting of the AUG-containing 10 
structural element may reflect its direct role in HIV-1 genomic RNA dimerisation in 11 
vitro. Similarly, blocking the 3‟ end sequences of the stem-loop domain containing the 12 
primer biding site interferes with RNA dimerisation. Targeting the apical portion of the 13 
TAR element, however, appears to promote dimerisation. ODNs targeted against the 14 
conserved polyadenylation signal [Poly(A)], the primer binding site (PBS), the major 15 
splicing donor (SD) or the major packaging signal (Psi), and AUG-containing 16 
structural elements led to a highly efficient inhibition of HIV-1 gene expression and 17 
virus production in cell culture. Together, these results support the idea that ODNs 18 
possess great potential as molecular tools for the functional characterisation of viral 19 
RNA structural domains. Moreover, the targeting of these domains leads to the 20 
potent inhibition of viral replication, underscoring the potential of conserved structural 21 
RNA elements as antiviral targets. 22 
 23 
Keywords: HIV-1, RNA dimerisation, genomic RNA structural domains, antiviral 24 
antisense ODNs, anti-HIV targets. 25 
26 
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1. Introduction 1 
 2 
The genomes of RNA viruses are multifunctional molecules. In retroviruses, including 3 
human immunodeficiency virus type 1 (HIV-1), they function as both mRNA and 4 
genomic RNA (gRNA). Infective HIV-1 viral particles contain two identical, non-5 
covalently linked gRNA molecules that bind in a process known as genomic RNA 6 
dimerisation (Paillart et al., 2004). It has been reported that RNA dimers are 7 
preferentially packaged over monomeric RNA genomes (Darlix et al., 1990; Fu and 8 
Rein, 1993). The dimeric state also facilitates template switching during reverse 9 
transcription, thus avoiding the problems that could be caused by any physical 10 
damage to one of the RNA monomers. It also favours recombination, increasing the 11 
genetic diversity and adaptability of retroviruses (Gotte et al., 1999). Electron 12 
microscopy studies of packaged retroviral gRNAs have revealed that the two RNA 13 
molecules attach to each other through the dimer linkage structure (DLS) in their 5‟ 14 
ends (Bender and Davidson, 1976; Hoglund et al., 1997). Using in vitro-transcribed 15 
short RNAs corresponding to various lengths of HIV-1 gRNA, it has been shown that 16 
the DLS includes the first 311 nucleotides of the HIV-1 5‟UTR (Marquet et al., 1994). 17 
This 5‟UTR is predicted to fold into a highly ordered secondary structure that has 18 
been experimentally modelled by computational, phylogenetic, biochemical and 19 
mutational probing studies (Damgaard et al., 2004; Kasprzak et al., 2005). Although 20 
minor variations exist, the consensus structure involves seven structural stem-loop 21 
motifs that represent independent functional elements (Fig. 1): the trans-activation 22 
region (TAR), the polyadenylation signal [Poly(A)], the primer binding site (PBS), the 23 
dimerisation initiation site (DIS or SL1), the  major splice donor site (SD or SL2), the 24 
genomic packing signal (Psi, ψ or SL3) and a stem-loop containing the AUG initiation 25 
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codon of the Gag open reading frame (AUG or SL4) (Berkhout, 1996). Mutational 1 
analysis indicates that the DIS domain is the most important element involved in in 2 
vitro dimerisation (Laughrea and Jette, 1994; Muriaux et al., 1995; Paillart et al., 3 
1994; Skripkin et al., 1994). Full-length leader RNA can adopt two alternative forms 4 
in vitro: the thermodynamically favoured leader RNA structure conformation, known 5 
as the long distance interaction (LDI) since it involves long distance base pairing 6 
between the Poly(A) and DIS (Huthoff and Berkhout, 2001); and the branched 7 
multiple hairpins (BMH) conformation. The folding of the BMH exposes the DIS-8 
containing hairpin structure, which has a 6-mer palindromic sequence closing loop 9 
(GCGCGC) important in RNA dimerisation. It has been described that only the BMH 10 
conformer can dimerise via an intermolecular interaction between the palindromes of 11 
two DIS elements (Clever et al., 1996; Haddrick et al., 1996; Laughrea and Jette, 12 
1994; Muriaux et al., 1995; Paillart et al., 1994; Skripkin et al., 1994). This initial 13 
structure is termed the kissing loop dimer complex, which subsequently progresses 14 
to a more stable extended duplex involving other nucleotides (Laughrea and Jette, 15 
1996a; Laughrea and Jette, 1996b; Muriaux et al., 1996). Recent studies indicate 16 
that gRNA dimerisation can be achieved without a functional DIS (Clever and 17 
Parslow, 1997; Laughrea et al., 1997; Shen et al., 2000; Shen et al., 2001). This 18 
suggests that one or more DIS-independent dimerisation sites exist in HIV-1 gRNA, 19 
though their precise molecular location remains unclear. Moreover, the originally 20 
identified DLS-encompassing sequence, which included bases 1-311 of the HIV-1 21 
5‟UTR, has undergone some refinement. Sakuragi et al. traced the sequence 22 
requirements of the DLS to a non-contiguous 144 nt region, consisting of sequences 23 
from the junction between the Poly(A) and PBS elements to the end of the AUG-24 
containing stem-loop (more specifically, nucleotide sequences 105-130, 217-281 and 25 
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301-352 of the HBX2 strain of HIV-1) (Sakuragi et al., 2007).  The roles of these 1 
regions in RNA-RNA interactions are still to be properly defined.  2 
 3 
Synthetic oligodeoxynucleotides (ODNs) complementary to HIV-1 RNA, and their 4 
derivatives, have great potential as tools for investigating the molecular biology of 5 
functional RNA elements. In their simplest form, these ODNs are introduced into the 6 
cell to block gene expression by interfering with translation of mRNA or by promoting 7 
the degradation of the target RNA via an RNase H-dependent pathway. Targeting 8 
with antisense ODNs can also provide information on the structure of a target RNA 9 
and can be used to block the access of other molecules to specific nucleic acid 10 
sequences. Traditionally, researchers attempting to inhibit gene expression with 11 
antisense ODNs avoid targeting regions with a stable secondary structure.  However, 12 
since stable structural RNA domains coincide with important functional elements, 13 
they represent potential targets for efficient inhibition. The binding of oligonucleotides 14 
to regions in the RNA that are predominantly double-stranded has previously been 15 
reported to be associated with a strong antisense response in vivo (Laptev et al., 16 
1994). The present study examines the potential of a set of unmodified antisense 17 
ODNs directed against the different stemp-loop structural elements of functional 18 
importance within the 5'UTR of HIV-1 gRNA, in the analysis of RNA dimerisation in 19 
vitro. It also examines the capacity of these ODNs to inhibit HIV-1 proliferation and 20 
gene expression in cell cultures. 21 
 22 
2. Materials and Methods 23 
 24 
2.1. Antisense and control oligonucleotides 25 
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ODNs were synthesized using an automated Applied Biosystems 3400 DNA 1 
synthesizer (Applied Biosystems, Foster City, CA, USA) using standard 2 
phosphoramidite chemistry. All ODNs were designed as 30 nt-long molecules, except 3 
for the 25 nt-long AUG-as complementary to a specific target site within the HIV-1 4 
5‟UTR genomic RNA.  All were named according to their target site (Table 1). Two 5 
control, non-specific oligonucleotides were designed: pLCX-30, which is 6 
complementary to no sequence motif of the HIV-1 genome, and a 30 nt-long random 7 
sequence (theoretically containing 7.2 x 1016 sequences).   8 
 9 
2.2. DNA templates and RNA synthesis 10 
The DNA template for the synthesis of the HIV-1 5‟UTR genomic RNA fragment was 11 
obtained by PCR amplification of the pUC18-based pNL4-3 plasmid (Adachi et al., 12 
1986). A T7 RNA-polymerase promoter sequence was incorporated by the sense 13 
PCR primer 5‟-T7pNL4-3: 5‟-TAATACGACTCACTATAGGGTCTCT CTGGTTAG-3‟ 14 
(the T7 promoter is indicated in bold). The 3‟pNL4-3-gag 15 
GCTTAATACCGACGCTCTC was used as a reverse PCR primer. The HIV-1NL4-3 16 
5‟UTR RNA fragment containing nucleotides 1-357 was obtained by in vitro 17 
transcription of the gel-purified PCR product, and purified as previously described 18 
(Barroso-delJesus et al., 1999). RNA was renatured by heating to 85°C followed by 19 
slow cooling to room temperature prior to use. 20 
 21 
2.3. In vitro RNase H cleavage assay 22 
Before digestion with Escherichia coli RNase H, 0.5 nM of 5‟ end 32P-labelled RNA 23 
transcript was renatured in 10X RNase H buffer (200 mM Tris-HCl pH 7.8, 400 mM 24 
KCl, 80 mM MgCl2, 10 mM DTT) by heating at 65°C for 3 min followed by slow 25 
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cooling to room temperature. The RNA transcript was incubated separately with each 1 
oligonucleotide (1 μM) for 30 min at 37ºC. Subsequently, 5 U of RNase H (Ambion, 2 
Austin, TX) was added to the mixtures and incubated at 37°C for 20 min. The 3 
reactions were quenched with equal volumes of 2X formamide gel loading buffer and 4 
loaded onto a 7 M urea 6% polyacrylamide denaturing gel in 1X TBE buffer. After 5 
electrophoretic resolution of the digestion products at 20 mA for approximately 6 
90 min, the gel was vacuum dried and analysed using a Typhoon 9400 scanner (GE 7 
Healthcare). 8 
 9 
2.4. In vitro dimerisation assay 10 
Four picomoles of unlabelled HIV-1NL4-3 5‟UTR transcript were added to 8 μl of Milli-Q 11 
(Millipore, Rockland, MA) water containing 0.05 pmol of radiolabelled HIVNL4-3-5‟UTR 12 
and 50 pmol of individual unlabelled antisense oligonucleotides or combinations of 13 
antisense oligonucleotides (50 pmol of each ODN included). Samples were 14 
denatured at 95ºC (2 min) and snap-cooled on ice. Dimerisation reactions were 15 
performed as described by (Sánchez-Luque et al., 2010). Briefly, the dimerisation 16 
reaction was initiated by adding 2 μl of 5X dimer buffer (1X: 50 mM sodium 17 
cacodylate, pH 7.5, 300 mM KCl and 5 mM MgCl2) at 37ºC for 45 min and then 18 
stopped by the addition of 2X gel loading buffer (Tris-acetate 20 mM, Mg acetate 10 19 
mM, NaCl 0.1 M, glycerol 30% v/v, xylene cyanol 0.4% p/v, bromophenol blue 0.4% 20 
p/v, tRNA 4% p/v). In parallel, RNA 1-357 was incubated in monomerisation buffer 21 
(50 mM sodium cacodylate, pH 7.5, 40 mM KCl and 0.1 mM MgCl2). Samples were 22 
analysed on 1% agarose gels in 1X TBM buffer (0.5X Tris-borate, 0.1 mM MgCl2). 23 
Electrophoresis (100 V) was performed in the same buffer at 4ºC for 2.5 h. Gels were 24 
fixed with 10% trichloroacetic acid for 10 min, dried for 1 h under vacuum at room 25 
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temperature, and exposed to phosphorimager screens from 4 h to „overnight‟. The 1 
dimerisation efficiency was calculated as [dimmer x 100 / (dimmer + monomer)]. Data 2 
are expressed at the mean ± standard deviation of three independent experiments. 3 
 4 
2.5. Cell culture and transfection 5 
The human embryonic kidney (HEK) cell-line 293T was maintained in Dulbecco‟s 6 
modified Eagle‟s medium (DEMN) supplemented with 10% foetal bovine serum (FBS; 7 
Gibco Invitrogen, San Diego, CA, USA), 100 μg/ml streptomycin (Sigma Chemical 8 
Co. St Louis, MO, USA), 4 mM L-glutamine (Sigma)  and  1 mM sodium pyruvate 9 
(Sigma).  Human T lymphocyte Jurkat cells were maintained in RPMI-1640 10 
supplemented with 10% FBS (Gibco), 4 mM L-glutamine (Sigma) and 100 μg/ml 11 
Streptomycin (Sigma). All cells were incubated at 37°C under humidified air 12 
containing 5% CO2. 13 
For the transfection of the HEK 293T cells, 1 X 105 cells were seeded in 1 ml of 14 
DMEM in 24-well culture plates. For the transfection of the Jurkat cells, 5 x 105 cells 15 
were seeded in 1 ml of RMPI.  Both cell lines were co-transfected with 100 pmol (0.2 16 
μM) of the ODNs and 100 ng of pNL4-3 plasmid complexed with 1 μl Fugene HD 17 
(Roche Diagnostics, Mannheim, Germany). At 6 h post-transfection, the HEK 293T 18 
cells were provided with fresh growth medium (to remove the transfection mixture) 19 
and further incubated at 37°C for 48 h. For the Jurkat cells, the transfection mixture 20 
was replaced by fresh growth medium after 4 h. Cells incubated with Fugene HD or 21 
medium alone were used as controls. The expression and replication of the HIV-1 22 
proviral clones were then monitored by determining viral p24 antigen in culture 23 
supernatants using an enzyme immunoassay (EIA, Bio-Rad Laboratories, Redmond, 24 
WA) and employing a Molecular Devices microplate reader. The results were 25 
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expressed as the mean ± standard deviation of at least three independent 1 
determinations.   2 
 3 
2.6. Quantitative real-time RT-PCR assays 4 
Quantitative real time RT-PCR analysis was performed 48 h after co-transfection. 5 
Total RNA was extracted with Trizol reagent (Invitrogen, San Diego, CA) according to 6 
the manufacturer‟s protocol. To remove potentially contaminating genomic DNA, all 7 
RNA samples were digested with RNase-free RQ1 DNase (Promega, Madison, WI, 8 
USA) at 37°C for 30 min followed by phenol-chloroform extraction. Total RNA (1 µg) 9 
was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit 10 
(Applied Biosystems) and random hexamers, according to the manufacturer‟s 11 
instructions. The cDNA was used as a template for quantitative qRT-PCR analysis 12 
using iTaq Fast SYBR Green Supermix with ROX (Bio-Rad Laboratories, Hercules, 13 
CA, USA), following the manufacturer's recommended conditions. Gene expression 14 
was normalized to the GAPDH expression levels for data analysis of each sample. 15 
The calibrator sample in real-time PCR was the cDNA from HEK 293T cells co-16 
transfected with pLCX-30. Data was analyzed using the comparative cycle threshold 17 
(Ct) method, as described (Livak and Schmittgen, 2001).  18 
 19 
3. Results 20 
 21 
3.1. Accessibility of structural HIV-1 5’UTR functional domains to specific 22 
antisense ODNs 23 
Target accessibility is a critical limitation of antisense applications. A set of antisense 24 
ODNs targeting the different structural RNA elements within the 5‟UTR of HIV-1 RNA 25 
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was designed (Table 1; Fig. 1). Access to the targeted genomic RNA domains by the 1 
ODNs was tested by RNase H digestion. For this, a 5‟ end 32P-labelled HIV-1-RNA 2 
fragment containing the first 357 nucleotides of HIV-1 gRNA was in vitro synthesized 3 
and subjected to RNase H digestion in the absence or presence of a molar excess of 4 
unlabelled antisense ODNs (Fig. 2). Complete cleavage of the 5‟UTR of HIV-1 gRNA 5 
was observed in the presence of the oligonucleotides TAR-as, PBS1-as, PBS2-as, 6 
PSB3-as, PSB4-as, SD-as, Psi-as and AUG-as, while cleavage efficiency was 7 
reduced to 71.4 % and 86.8 % in the presence of Poly(A)-as or DIS-as. These results 8 
indicate that the different targeted sequences within the HIV-1 5‟UTR structural 9 
elements are accessible to their specific ODNs. No cleavage products were detected 10 
in the presence of the negative control ODNs pLCX-30 and Random-30. 11 
  12 
3.2. Effect of the 5’UTR-antisense ODNs on the in vitro dimerisation of HIV-1 13 
RNA 14 
In vitro RNA dimerisation assays were performed in the presence of the specific 15 
antisense ODNs targeting each of the functional elements within the 5‟UTR, in order 16 
to analyse their putative role in this essential viral process. Briefly, 50 pmol of each 17 
antisense ODN was independently incubated with 4 pmol of unlabelled HIV-1 RNA 1-18 
357, contaminated with traces of internally 32P-labelled HIV-1 RNA 1-357 (see 19 
Materials and methods), which includes the entire 5‟UTR and the first 22 nucleotides 20 
of gag ORF, under the dimerisation conditions described in Materials and Methods 21 
(Fig 3). Under these high ionic strength conditions, ≥60% of the 1-357 transcripts 22 
entered into a dimer complex (under low ionic strength the monomer status is entirely 23 
predominant; no dimers are detected). As expected, nearly complete inhibition of 24 
dimer formation was observed in the presence of the DIS antisense ODN (DIS-as), 25 
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confirming the DIS element to be the major dimerisation site and corroborating 1 
previous observations suggesting dimerisation to be essentially governed by the DIS 2 
element taking part in a reversible apical loop-apical loop interaction (Paillart et al., 3 
1996). Strong dimerisation inhibition was also detected when blocking the SD domain 4 
with the corresponding antisense ODN (only 24% dimerisation was seen in the 5 
presence of SD-as). RNA dimerisation inhibition was also observed with ODNs 6 
complementary to the Psi and AUG regions (Fig. 3, Lanes 13 and 14). These results 7 
indicate the potential involvement of the SD, Psi and AUG elements in RNA 8 
dimerisation. Surprisingly, a larger RNA dimerisation yield (93%) was obtained in the 9 
presence of the anti-TAR ODN (TAR-as). This suggests that the TAR element has a 10 
negative effect on RNA dimerisation. Similarly, an increase in the dimer yield was 11 
observed in the presence of Poly(A)-as, PBS1-as and PBS4-as. No effect was 12 
observed in the presence of PBS2-as or PBS3-as (Fig. 3, Lanes 8 and 9), nor in the 13 
presence of the control ODNs pLCX-30-as and Random-30-as.  14 
 15 
3.3. Interference of the RNA dimerisation by targeting the AUG-containing 16 
structural element  17 
A number of authors have indicated that dimerisation can take place in the absence 18 
of a functional DIS element. This suggests that other elements act as secondary 19 
dimerisation initiation sites (Berkhout, 1996; Haddrick et al., 1996; Sakuragi and 20 
Panganiban, 1997; Shen et al., 2000) but whose contribution goes unnoticed in the 21 
presence of a functional DIS element. The role in dimerisation of the different 22 
structural elements within the 5‟UTR was therefore examined in a DIS-depleted 23 
functional background. For this, in vitro dimerisation was assayed in the presence of 24 
a combination of specific ODNs and DIS-as (to obtain the required background) (Fig. 25 
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4). No inhibitory effect beyond that associated with DIS-as was observed with the 1 
addition of the ODNs SD-as or Psi-as (Fig. 4; compare Lanes 5 and 6 to Lane 4), 2 
suggesting that SD and Psi played no direct or DIS-independent role in RNA 3 
dimerisation. Interestingly, the subsequent addition of AUG-as abolished the 4 
formation of RNA dimers (Fig. 4, Lane 7). This, together with the partial inhibitory 5 
effect observed when blocking only the AUG region (Fig. 3, Lane 14), suggests that 6 
the AUG region may play a direct role in RNA dimerisation, though we cannot rule 7 
out the possibility of an indirect effect on dimerisation due to the induction of 8 
structural modifications in the HIV RNA. Finally, the addition of TAR-as (Fig. 4, Lane 9 
8) partially restored the dimerisation capability of the gRNA, which is in good 10 
agreement with results shown in Figure 3.  11 
 12 
3.4. Involvement of the PBS element in RNA dimerisation 13 
An analysis of the potential role in RNA dimerisation of the structural domain 14 
containing the PBS element was undertaken in a DIS-blocked background (Fig. 5). 15 
The addition of PBS1-as or PBS4-as resulted in no significant effect (compare Lanes 16 
3 and 6 with Lane 2). However, a clear promotion of RNA dimerisation was observed 17 
in the presence of PBS2-as or PBS3-as or both. These results indicate that their nt 18 
107-136 and 142-171 target regions might negatively affect dimerisation. 19 
Interestingly, when PBS2-as and/or PBS3-as were combined with PBS1-as, but not 20 
with PBS4-as, the efficiency of dimerisation was inhibited. This suggests that the 21 
target sequence of the PBS1-as (nt 210-239) in the structural motif-containing the 22 
PBS element may play a direct role in promoting HIV-1 gRNA dimerisation.  23 
 24 
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3.5. Inhibition of HIV-1 production and gene expression by antisense 1 
oligonucleotides 2 
All the targeted HIV-1 structural elements play essential roles in the viral cycle. Since 3 
the antisense ODNs bound efficiently to the different functional 5‟UTR structural 4 
elements, their effect on viral particles production and HIV-1 gene expression in cell 5 
culture was also tested. For this, HEK 293T and Jurkat cells were co-transfected with 6 
the pNL4-3 plasmid and a set of specific ODNs. Transfection with pro-viral DNA 7 
mimics the post-integration stage of the viral cycle. The effect of the antisense ODNs 8 
measured as viral p24 antigen levels in the supernatant, in both cell lines was 9 
quantified at 48 h post-transfection, at which viral particles in the supernatant should 10 
correspond to first generation virions. A reduction in viral production was observed 11 
with Poly(A)-as, pBS1-as pBS2-as, pBS3-as, SD-as and Psi-as (Fig. 6),whereas no 12 
inhibitory effect was seen for TAR-as, PBS4-as or DIS-as. These results suggest that 13 
Poly(A)-as, pBS1-as pBS2-as, pBS3-as, SD-as and Psi-as are functional in cells of 14 
lymphoid origin, and highlight the potential of the motifs they seek out as antiviral 15 
targets in human T cell cultures. 16 
Antisense activity might be achieved through RNase H-mediated degradation of the 17 
target RNA. To confirm that the ODNs reduced the steady-state levels of HIV-1 RNA 18 
in co-transfected HEK 293T cells, HIV-1-5‟UTR RNA was quantified by real time RT-19 
PCR at 48 h post-transfection. The results in Figure 7 show a significant reduction in 20 
viral RNA after transient transfection with Poly(A)-as, pBS1-as pBS2-as, pBS3-as, 21 
SD-as, Psi-as and AUG-as; this correlates perfectly with the reduction seen in viral 22 
p24 antigen levels (Fig. 6). 23 
 24 
4. Discussion 25 
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 1 
A major concern in the design of efficient antisense ODNs against highly structured 2 
viral RNA genomes is the accessibility of the target sequences. A correlation 3 
between in vitro accessibility and the intracellular activity of antisense ODNs has 4 
been reported for several target RNAs (Ho et al., 1998; Ho et al., 1996; Matveeva et 5 
al., 1997; Southern et al., 1997). Since the HIV-1 5‟UTR is folded into a complex 6 
secondary and tertiary structure, it might be thought that many potential target sites 7 
become inaccessible. However, the present results indicate that the different 8 
structural elements of the 5‟UTR remain accessible to antisense ODNs (Fig. 2). The 9 
partial discrepancies with the results of other authors (Ooms et al., 2004) in terms of 10 
5‟UTR accessibility may be due to differences in the experimental conditions, the 11 
length of the oligonucleotides used, or differences in the target sequences. 12 
Deletions that affect the TAR element are thought to result in increased in vitro HIV-13 
1-RNA dimerisation (Vrolijk et al., 2008). This would agree with the effects observed 14 
in the present work when TAR-as was introduced into the system (Fig. 3, Lane 5; Fig. 15 
4, Lane 8). Although the TAR element itself is not directly involved in the switch from 16 
LDI to BMH conformers -since it is conserved in both conformations- the 17 
destabilisation of TAR may affect LDI-BMH equilibrium and thus indirectly influence 18 
other functional RNA elements. In contrast to that seen in the present work, evidence 19 
exists that the TAR element makes a positive contribution to RNA dimerisation in 20 
vitro (Andersen et al., 2004). However, the latter authors performed their dimerisation 21 
assays in the presence of the nucleocapsid protein, which may explain the lack of 22 
agreement with the present data. The validation of these in vitro interaction studies in 23 
a cellular system that permits viral replication is essential since different long-range 24 
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RNA-RNA interactions, among other factors, might influence the ability of HIV-1 RNA 1 
to dimerise.   2 
DIS-as essentially blocked dimerisation, probably sequestering the palindromic 3 
sequences in the DIS loop, and interfering in the kissing-loop interaction. The in vitro 4 
dimerisation inhibition exerted by SD-as might be a consequence of the close 5 
proximity of its 3‟ end binding site to the highly conserved AGG loop at the base of 6 
the DIS element stem (position 271-273), which has been implicated in dimerisation 7 
(Clever and Parslow, 1997; Greatorex et al., 2002; Takahashi et al., 2000). SD-as 8 
may have also an indirect effect on dimerisation via its altering the structure of the 9 
DIS element; this may affect the distal-loop sequence involved in the kissing-loop 10 
interaction. Blocking of the SD structural domain partially inhibited RNA dimerisation 11 
(Fig. 3), but no additional inhibitory effect was observed when it was combined with 12 
DIS-as (Fig. 4). Similar behaviour was recorded with respect to the modest inhibition 13 
achieved with Psi-as. These results suggest that SD and Psi play no DIS-14 
independent role in RNA dimerisation. According with a previous work describing that 15 
destabilization of the LDI conformer by targeting the 5‟ UTR with oligonucleotides 16 
induced the switch to the BMH dimerisation competent conformer (Berkhout et al., 17 
2002), the ODN effects described here can be attributed to structure alterations 18 
challenging the DIS functionality.  19 
Interestingly, the remaining RNA dimerisation activity observed in the presence of 20 
DIS-as, SD-as and Psi-as was abolished with the addition of AUG-as (Fig. 4). Since 21 
this effect was observed in a DIS-blocked background our data suggest that the 22 
sequence surrounding the AUG initiation codon might provide a dimerisation site. 23 
Nevertheless we cannot discard an indirect effect of the AUG-as by affecting the 24 
structure of the 5‟UTR influencing the exposure of a hypothetically remaining 25 
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functional DIS element responsible of the observed 10% of RNA dimmers in the 1 
presence of the DIS-as. A long-distance base pairing between the linker sequences 2 
of poly(A) and the PBS elements plus the nucleotides surrounding the AUG Gag 3 
initiation codon has been described (Abbink and Berkhout, 2003). The resulting 4 
interaction yields the so called U5-AUG duplex. This may explain the present results 5 
that suggest the AUG-containing domain might play a direct role in RNA dimerisation. 6 
Such a role is supported by the observation that the AUG effect is summatory to that 7 
associated with DIS rather than synergistic. DIS-as reduces dimerisation from 60% to 8 
10%, AUG-as from 60% to 50% and both from 60% to 0%, suggesting that the 9 
effects of these two regions are independent of one another.  10 
Evidence that the extended PBS-containing stem-loop motif contributes to gRNA 11 
dimerisation was first provided by the effect of deleting nt 200-226 or 236-242 in 12 
virions produced by Cos-7 cells (Shen et al., 2000). The present results show that 13 
while antisense ODNs targeting the 5‟ strand of the PBS-containing the stem-loop 14 
motif have little or no impact on gRNA dimerisation (PBS2-as and PBS3-as), blocking 15 
the 3‟ end nt positions 178-207 and 210-239 segments with PBS4-as and PBS1-as 16 
respectively promoted dimerisation in a functional DIS background (Fig. 3). However, 17 
in a non-functional DIS background, clear promotion of dimerisation was observed 18 
when the region comprised between nt 210 and 239 was accessible (Fig. 5). The 19 
negative effect of other regions of the PBS-containing structural motif may be due to 20 
the sequestering of the nt 210-239 sequences. Thus it seems necessary to block its 21 
complementary sequence with PBS2-as for the promotion of dimerisation by the 22 
sequences at the 3‟ end of the PBS-containing element to occur. It is noteworthy that 23 
this region contains an imperfect palindromic sequence (GAGAUCUCUC), and that 24 
this might be involved in this process. Further (Sakuragi et al., 2012) have recently 25 
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found highly conserved complementary sequences located upstream of the DIS stem 1 
(GACGC) and at the 3‟ end of the DLS (GCGUC). Their data strongly suggest that 2 
both sequences interact and the duplex formation (GACGC-GCGUC) occurs within 3 
the virus playing an important role for DLS function. Interestingly, in our dimerisation 4 
assays the sequence GACGC is blocked by the PSB1-as. In a functional DIS 5 
background the opposite effect to that observed with PBS1-as and PBS4-as may be 6 
due to the stabilisation of the functional DIS structural motif.  7 
In addition to their effect on dimerisation, the assayed antisense ODNs may interfere 8 
with other essential steps in the viral cycle. This would explain the significant antiviral 9 
activity of Poly(A)-as, PBS1-as, PBS2-as, PBS3-as, SD-as, Psi-as and AUG-as 10 
observed in cell culture. Antisense ODNs targeting the PBS1, PBS2 or PBS3 11 
sequences may interfere with tRNA binding to the PBS motif and the subsequent 12 
initiation of reverse transcription. SD-as covers the major splice donor site and may 13 
therefore interfere with splice site recognition, but also with RNA packaging since the 14 
SD region contributes to this process (Amarasinghe et al., 2000; Amarasinghe et al., 15 
2001). Psi-as may interfere with genomic RNA encapsidation. Finally AUG-as may 16 
block the HIV translation initiation. Nevertheless we cannot discard an effect of the 17 
ODNs on the viral infectious DNA. 18 
 19 
5. Conclusions 20 
 21 
The present results show that antisense oligonucleotides are excellent tools for 22 
deciphering the functional implications of structural RNA domains, and provide 23 
evidence that may suggests a direct role of the AUG-containing RNA element and 24 
the 3‟ end sequence of the PBS-containing structural domain in the dimerisation of 25 
18 
 
genomic HIV-1 RNA. In contrast, the apical portion of the TAR stem-loop element 1 
seems to play a negative role in RNA dimerisation. ODNs are also shown to be 2 
excellent tools for exploring the potential of conserved structural RNA elements as 3 
antiviral targets. 4 
 5 
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 38 
Figure legends: 39 
 40 
Figure 1. Sequence and secondary structure of the 5'UTR of HIV-1. Sequence 41 
and secondary structural model of the 5‟UTR of the HIV-1 gRNA adapted from 42 
Berkhout (Berkhout, 1996). The main stem-loop structural domains associated with 43 
22 
 
known functions are shown. Antisense ODNs are indicated by a solid line mapping 1 
their corresponding complementary target sequences within the HIV-1 5‟UTR.  2 
 3 
Figure 2. Accessibility of target structural domains within the HIV-1 5'UTR. 4 
Representative autoradiograph of an electrophoretic gel resolving the RNase H-5 
cleaved RNA fragments of the HIV-1 5‟UTR in the presence of different antisense 6 
ODNs (indicated at the top of each lane). Lane 13: undigested full length 32P-labelled 7 
HIV-1 5‟UTR transcript. M: RNA size marker (Century marker, Ambion). 8 
 9 
Figure 3. In vitro effect of antisense oligonucleotides on the dimerisation of 10 
HIV-1 gRNA. Autoradiograph of a representative electrophoretic gel from an RNA 11 
dimerisation assay. HIV-1 5‟UTR transcript (1-357 nt) was incubated under 12 
monomerisation (Lane 1) and dimerisation conditions in the absence (lane 2) and 13 
presence of specific antisense ODNs (indicated at the top of the gel). The positions of 14 
dimer (D) and monomer (M) RNA species are indicated with arrowheads to the left of 15 
the gel. Dimerisation efficiency, indicated below, indicated at the bottom, represents 16 
the average of three independent experiments ± SD. 17 
 18 
Figure 4. The AUG-containing structural domain promotes HIV-1 RNA 19 
dimerisation. Autoradiograph of a representative electrophoretic gel from an RNA 20 
dimerisation assay. HIV-1 5‟UTR transcript (1-357 nt) was incubated under 21 
dimerisation conditions in the presence (+) or absence (–) of different combinations 22 
of antisense ODNs (indicated at the bottom of the gel). The positions of monomer (M) 23 
and dimer (D) RNA species are indicated with arrowheads at the left. Lane 1, HIV-1 24 
5‟UTR transcript incubated under monomeric conditions. Dimerisation efficiency, 25 
23 
 
indicated at the bottom, represents the average of three independent experiments ± 1 
SD. 2 
 3 
Figure 5. The 3’ end sequence of the PBS-containing structural domain 4 
promotes HIV-1 RNA dimerisation. Autoradiograph of a representative 5 
electrophoretic gel from an RNA dimerisation assay. HIV-1 5‟UTR transcript (1-357 6 
nt) was incubated under dimerisation conditions in the presence (+) or absence (-) of 7 
different combinations of antisense ODNs (indicated at the bottom of the gel). The 8 
positions of monomer (M) and dimer (D) RNA species are indicated with arrowheads 9 
at the left. Dimerisation efficiency, indicated at the bottom represents the average of 10 
at least three independent experiments ± SD. 11 
 12 
Figure 6. Inhibition of HIV-1 replication in human cells. (A) HEK 293T and (B) 13 
Jurkat cells were co-transfected with 100 ng of pNL4-3 plasmid and 100 pmol of 14 
control or antisense ODNs. Viral production was determined by measuring viral p24 15 
antigen in the supernatant 48 h after co-transfection. The data shown represent the 16 
average of at least three independent experiments; standard deviations are indicated 17 
by the error bars.  18 
 19 
Figure 7. Reduction of HIV-1 RNA levels in human cells by antisense ODNs. 20 
HEK 293T cells were co-transfected with 100 ng of pNL4-3 plasmid and 100 pmol of 21 
antisense ODNs. After 48 h of co-transfection, total RNA was extracted from the HEK 22 
293T cells and the 5‟UTR of the HIV-1 RNA content quantified. RNA amounts are 23 
represented as a percentage of the RNA level in the presence of the control pLCX-30 24 
ODN. The results are the mean of three independent experiments.   25 
24 
 
 1 
  
Table 1. Antisense and control ODN sequences used in this study. The nt coordinates of 
the binding sites are based on Figure 1. N=A, C, G, or T 
 
 
 
ODN 
 
                    Sequence (5’ to 3’) 
 
HIV-1NL4-3 5’UTR 
binding site 
pLCX-30 (control) GACGTCGAGTGCCCGAAGGATAGCTATCAG - 
Random-30 (control) N30 - 
TAR-1-as AGCCAGAGAGCTCCCAGGCTCAGATCTGGT 16-45 
Poly(A)-as GAGCACTCAAGGCAAGCTTTATTGAGGCTT 95-66 
PBS1-as TGCGTCGAGAGATCTCCTCTGGCTTTACTT 210-239 
PBS2-as TAGTTACCAGAGTCACACAACAGACGGGCA 107-136 
PBS3-as TTT TCCACACTGACTAAAAGGGTCTGAGGG 142-171 
PBS4-as GCTTTCAAGTCCCTGTTCGGGCGCCACTGC 178-207 
DIS-as CTCTTGCCGTGCGCGCTTCAGCAAGCCGAG 243-252 
SD-as TTTGGCGTACTCACCAGTCGCCGCCCCTCG 274-303 
Psi-as CTC TCCTTCTAGCCTCCGCTAGTCAAAATT 304-333 
AUG-as CTCTCGCACCCATCTCTCTCCTTCT 325-348 
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